Kyverna Therapeutics has filed with the U.S. Securities and Exchange Commission to raise $200,000,000.00 in an Initial Public Offering
According to filings with the U.S. Securities and Exchange Commission, Kyverna Therapeutics is raising $200,000,000.00 in new funding. About Kyverna Therapeutics: Kyverna Therapeutics is a clinical-stage cell therapy company with the mission of engineering a…